Sagility India Limited is a technology-enabled company which specializes in healthcare-related services and only serves the United States healthcare market. The company, formerly called Berkmeer India Pvt. Ltd, was incorporated in July 2021, and is in a niche but high outsourcing business that serves health insurers (payers) and health care providers. Sagility Share Price is ₹ 53.0 as of 2nd January 2026. Sagility is a company that provides important backend, analytics, and revenue-oriented services to assist US healthcare organizations to enhance efficiency, compliance, and cost management.
The Sagility BV, supported by the Everest Group, has encouraged the idea of agility, and when it comes to being listed, Sagility BV is a relatively new company (IPO 2024), though its parent business has decades of legacy. It has continuously decreased the debt level, assimilated profitability, and increased institutional ownership, making it a scalable healthcare IT-enabled services (ITES) provider.
This article provides detailed overview on Sagility Share Price: Today Price, NSE & BSE Price, Target 2030, and More
Company Overview
Sagility is a company that works at the convergence of data analytics, computerised automation of digital processes, and healthcare operations. Sagility serves only US-based clients because it focuses exclusively on healthcare IT services, unlike generic IT service providers. As of 2023, it had approximately 1.23 percent of the healthcare outsourcing market in the US, both to payers and providers.
The services offered by the company are highly integrated into mission-based healthcare processes including claims processing, payment integrity, clinical management and revenue cycle management (RCM). In 2024, its IPO strengthened the balance sheet and increased its visibility to investors on the Indian public market, with the market capitalization surpassing 24 000 crore.
The table below provides a snapshot of Sagility’s basic corporate and stock-market information.
| Particulars | Details |
| Company Name | Sagility India Limited |
| Former Name | Berkmeer India Pvt. Ltd. |
| Incorporation | July 2021 |
| Headquarters | Bengaluru, Karnataka |
| Industry | Healthcare IT & ITES |
| Primary Market | United States |
| Listing | NSE & BSE |
| Face Value | ₹10 |
| Market Capitalization | ₹24,432 Cr |
| Current Price | ₹52.97 |
Sagility Business Model and Client Segmentation
The business model of Sagility is created around long-term contracts with US healthcare organizations. The revenue models of the company include transaction-based and outcome-based pricing models that bring stability and predictability to the company.
The company has two client segments which are different and complementary with each segment carrying its own share in terms of revenues and growth.
The following table explains Sagility’s two core customer segments and the nature of services offered to each.
| Segment | Client Type | Key Services |
| Payers | Health insurance companies | Claims processing, payment integrity, utilization management, clinical services |
| Providers | Hospitals, physicians, diagnostic centers | Revenue cycle management, billing, AR follow-ups, insurance verification |
Services Portfolio
Sagility offers both business process and analytics and automation-based end-to-end support in healthcare operations. Sagility designs its services to help US healthcare entities reduce costs, improve service accuracy, and maintain regulatory compliance.
| Service Category | Description |
| Claims Management | End-to-end claims adjudication, processing, and audits |
| Payment Integrity | Fraud detection, overpayment recovery, and compliance |
| Clinical Management | Care management, utilization review, quality reporting |
| Revenue Cycle Management (RCM) | Billing, coding, collections, denial management |
| Data & Analytics | Insights, reporting, and predictive healthcare analytics |
Sagility’s strong domain expertise differentiates it from horizontal ITES peers.
Sagility share Recent Performance Overview
The price movement of Sagility at the end of December 2025 suggests that the company is active in terms of activity of market participants on both exchanges. The stock had traded in a small intraday band, but still displayed characteristic of caution as a result of valuation issues and overall trends in the IT industry. Trading volumes were also healthy reflecting a longer-term interest of the investors even though the short-term price pressure exists. The major valuation ratios indicate that the stock is overvalued based on book value which is backed up by the growth in earnings.
| Metric | Details |
| NSE Price | ₹52.97 |
| BSE Price | ₹52.23 |
| Day Change | -0.74% |
| Market Capitalization | ₹24,451 Cr |
| 52-Week High | ₹57.90 |
| 52-Week Low | ₹37.61 |
| P/E Ratio | 30.54 |
| Book Value | ₹19 |
| Price-to-Book | 2.75x |
NSE Trading Details
| Particulars | Value |
| Symbol | SAGILITY |
| ISIN | INE0W2G01015 |
| Open Price | ₹52.65 |
| Day High | ₹53.25 |
| Day Low | ₹52.10 |
| Previous Close | ₹52.63 |
| Day Change | -0.78% |
Sagility share BSE Trading Details
The BSE price action is more or less comparable to that of NSE whereby slight variations are a result of volume distribution. The stock ended slightly down and traders traded the value moderately, which showed that there was no panic selling but the participation was of an average nature. The BSE performance in one year is below the performance of the benchmark indices and this has continued to make valuation debates alive among investors. However, the recent quarterly profit growth has assisted in curbing the further downsides.
BSE Price Details
| Particulars | Value |
| BSE Code | 544282 |
| Closing Price | ₹52.97 |
| Traded Value | ₹3.41 Cr |
| Shares Traded | 6,53,375 |
| Face Value | ₹10 |
| 1-Year Return | -2.94% |
Sagility share Price Historical Performance
The price history of Sagility reveals a sharp fluctuation as it is a characteristic of the newly listed mid-cap ITES companies. Its stock has been very strong since the post listing lows but has had difficulty maintaining the stock at 52 week highs. Short-term momentum has been good in recent months despite longer-term returns being downplayed. This is a mixed result of the wait-and-watch attitudes of the market to the sustainability of profitability and the ratios of returns.
| Period | BSE Return | NSE Return | Nifty Return |
| 1 Week | -1.23% | -18.90% | -0.88% |
| 1 Month | 4.36% | -14.42% | -1.00% |
| 3 Months | 21.61% | -0.28% | 5.31% |
| 1 Year | -2.94% | -20.42% | 8.94% |
Share Price Targets for 2025
The analysts mostly have positive expectations for the year 2025, and the high demand for healthcare outsourcing services in the US backs this. The majority of brokerage and research websites predict average returns between the current and future positions, assuming no change in margins and slow growth in the ratio of returns. The target prices depend on the valuation methodology, and those processes based on EV/EBITDA are better than intrinsic value-based models. The mood regarding 2025 is generally accumulation as opposed to selling aggressively.
2025 Share Price Targets
| Source | Rating | Average Target | Implied Upside |
| IndMoney (9 Analysts) | Buy | ₹62.78 | +21% |
| Investing.com | Strong Buy | ₹59 | +13% |
| TradingView | Buy | ₹66.22 | +27% |
| AlphaSpread | Buy | ₹63.85 | +23% |
Sagility share Price 2027 Targets
There are a lot of divergences in longer run projections mostly on assumption of revenue CAGR and margin growth. The conservative estimates have anticipated moderate appreciation with the growth in earnings, whereas the aggressive forecasts have taken into consideration strong tails of healthcare BPO. The majority of realistic models attribute fair value to slower rising trend as opposed to higher growth in a straight line. The ROE improvement and management of the client concentration will be significant in long-term performance.
| Scenario | Expected Range |
| Conservative | ₹60 – ₹66 |
| Base Case | ₹85 – ₹100 |
| Bullish (High Risk) | ₹120+ |
Sagility share Ipo Details
The offer-for-sale (OFS) IPO, which completely involved the sale of existing promoter shares, constituted a 2,107 crore IPO with a total of 70.22 crore shares sold by the existing promoters, and the company raised no additional capital. The distribution of issues was very much biased towards the institutions investors in the sense that 75 percent of the issues was allocated to the QIBs, 15 percent to the NIIs, and 10 percent to the retail investors and employees were given a modest reservation of about 0.5 percent but at a discount of 2. The authority would allow the retail investors to apply for a minimum number of one lot of 500 shares at a minimum investment of 30 records of 15000 at the higher price band of 30.
The IPO was characterized by an overall subscription of approximately 3. 2-3.73 times by the last day due primarily to the high retail subscription. The QIBs experienced an oversubscription of approximately 2.5 times, while retail investors overwhelmingly oversubscribed their share, which was approximately 3.7-4 times, placing bids way above the number of shares being offered. Conversely, non-institutional investors (NIIS) demonstrated restrained interest at approximately 0.7 times subscription which means that high-net-worth bidders were wary of the activity rather than retail investors.
Sagility share Price 2030
Share price outlook of Sagility India Limited differs extensively as per the forecasts. Conservative estimates suggest that the stock is in the range of 100-160, taking into consideration a slow but steady growth in healthcare outsourcing in the US and a moderate margin growth. Bullish forecasts are as high as ₹280-420, owing to the expectation of AI-based automation and increased profitability, but they have more risk because of low ROE and high stock volatility. The more conservative range is on the whole more aligned to the long-term view that is more realistic, and the upside is pegged on good execution.
| Forecast Type | Expected Range | Key Assumption |
| Conservative | ₹100 – ₹160 | Steady growth, margin stability |
| Bullish | ₹280 – ₹420 | AI automation, high EBITDA margins |
Note: These targets are indicative estimates, not guaranteed outcomes, and depend heavily on long-term execution and market conditions.
Sagility share Financial Performance – Quarterly Trends
Sagility has demonstrated a consistent increase in revenue as well as operating profits, underpinned by stability of margins and the increasing scale. Although margins vary on a quarter-to-quarter basis, the trend in the long-term is positive.
Before analyzing the data, one should mention that operating margins have mostly remained within the 20-25 range, which is healthy in the case of healthcare ITES.
Quarterly Financial Performance (₹ Crore)
| Quarter | Sales | Operating Profit | OPM % | Net Profit | EPS (₹) |
| Jun 2023 | 1,116 | 264 | 24% | 42 | 0.22 |
| Dec 2023 | 1,260 | 260 | 21% | 71 | 0.37 |
| Jun 2024 | 1,223 | 194 | 16% | 22 | 0.05 |
| Dec 2024 | 1,453 | 392 | 27% | 217 | 0.46 |
| Jun 2025 | 1,539 | 346 | 22% | 149 | 0.32 |
| Sep 2025 | 1,658 | 415 | 25% | 251 | 0.54 |
The improvement in net profit during FY25 highlights operating leverage and better cost control.
Sagility share Profit & Loss Analysis
The long term financials of Sagility Share Price indicate an increase in revenue and a steep improvement in the profits of the company in the past three years. The business shifted towards poor profitability to high profits as the scale increased.
The table below summarizes its consolidated profit and loss performance.
Profit & Loss Summary (₹ Crore)
| Year | Sales | Operating Profit | Net Profit | EPS (₹) |
| FY2023 | 4,218 | 1,039 | 144 | 0.75 |
| FY2024 | 4,754 | 1,088 | 228 | 0.53 |
| FY2025 | 5,570 | 1,307 | 539 | 1.15 |
| TTM | 6,219 | 1,526 | 799 | 1.71 |
Profit CAGR over three years stands at 291%, reflecting rapid earnings normalization.
Sagility share Balance Sheet Strength
One of the most notable strengths of Sagility is that the company has greatly minimized its debts within the past several years. Reduced borrowings have enhanced financial stability and lowered interest. Before reviewing the numbers, note the sharp decline in borrowings from FY2022 to FY2025.
Balance Sheet Snapshot (₹ Crore)
| Particulars | FY2023 | FY2024 | FY2025 |
| Equity Capital | 1,919 | 4,285 | 4,679 |
| Reserves | 4,288 | 2,158 | 3,657 |
| Borrowings | 2,896 | 2,532 | 1,402 |
| Total Assets | 10,529 | 10,529 | 10,917 |
Debt reduction has been a key factor behind improved profitability.
Sagility share Cash Flow Analysis
The trends of cash flows show that the efficiency of operations is rising. Cash flows have been robust in operation and the outlay of the cash in investment is an expression of technology and capability growth.
Cash Flow Statement (₹ Crore)
| Year | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow |
| FY2023 | 857 | -101 | -545 |
| FY2024 | 973 | -463 | -751 |
| FY2025 | 1,214 | -958 | -256 |
Strong operating cash generation supports sustainable growth.
Sagility share Key Ratios and Returns
Despite improving profits, Sagility’s return ratios remain modest compared to peers, mainly due to high equity base post-IPO.
| Ratio | FY2025 |
| ROCE | 9.58% |
| ROE | 7.38% |
| Stock P/E | 30.6 |
| Book Value | ₹19.0 |
| Dividend Yield | 0.10% |
Return ratios are expected to improve gradually as earnings compound.
Peer Comparison
Sagility operates in the IT-enabled services space but differs from traditional IT firms due to its healthcare specialization.
| Company | CMP (₹) | P/E | Market Cap (₹ Cr) | ROCE % |
| L&T Technology Services | 4,438 | 36.9 | 47,099 | 28.3 |
| Tata Technologies | 639 | 37.4 | 25,919 | 25.8 |
| Sagility India | 52 | 30.6 | 24,432 | 9.6 |
Sagility trades at a reasonable valuation but lags peers on returns.
Shareholding Pattern
Institutional participation has increased steadily, indicating growing confidence in the company’s prospects.
| Category | Holding % |
| Promoters | 67.38% |
| FIIs | 5.59% |
| DIIs | 14.87% |
| Public | 12.15% |
Conclusion
Sagility India Limited is a firm that has become a target healthcare IT-enabled services provider with an extensive understanding of the US healthcare outsourcing market. Its robust increase in revenues, steady operating margins and high debt reduction reflect its improving financial health. Although the ratio of returns is still low, and the reliance on the US market is still a risk, Sagility has a niche position, long-term client contracts, and increasing institutional interest that makes it a company with long-term stability instead of short-term fluctuations and Sagility Share Price are best share price in Healthcare Sector .
FAQs
Sagility offers technology-based healthcare services, including claims, revenue cycle, and clinical support, to healthcare payers and providers in the US.
The healthcare market of the United States is the only market served by Sagility.
Yes, the company has demonstrated good growth in profitability in the past years as the net profits increased.
The greatest risk is its total reliance on the US healthcare market and control system.
No, Sagility has been decreasing its debt over the last few years and this has enhanced its balance sheet position.
Read More:
Nai Taiyari.com Review 2026: Tech Tips, Free Recharge, Income Earning and More
Hearzap Smart Hearing: Services, Price Range, Features, APP, Centers and more
